SLK and hepatocellular carcinoma: The two SRSF3‐promoted exons (INSR and SLK) were decreased (p = 9.05e‐19 and 1.13e‐19), whereas the two SRSF3‐inhibited exons (FN1 and MYO1B) were increased in HCC (p = 2.7e‐64 and 1.23e‐6).